Free Trial
→ Here’s How to Claim Your Stake in Elon’s Private Company, xAI (From Brownstone Research) (Ad) Buy KAPA Stock  Free KAPA Stock Alerts

Kairos Pharma (KAPA) SEC Filings & 10K Form

Kairos Pharma logo
$1.06 +0.12 (+12.77%)
As of 04/4/2025 04:10 PM Eastern
Compare

Recent Kairos Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
03/20/2025
6:30 AM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
6:05 AM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
5:51 PM		Kairos Pharma (Issuer)
Yu John S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:52 PM		Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:45 PM		Kairos Pharma (Filer)
Form DEF 14C
02/06/2025
8:00 AM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
11:15 PM		Kairos Pharma (Filer)
Form EFFECT
02/05/2025
5:15 AM		Kairos Pharma (Filer)
Form 424B3
01/29/2025
6:22 AM		Kairos Pharma (Filer)
Form PRE 14C
01/29/2025
5:39 AM		Kairos Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
4:20 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
8:41 AM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
7:30 PM		Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
5:03 AM		Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
8:53 PM		Kairos Pharma (Issuer)
Yu John S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:48 AM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
1:19 PM		Kairos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:30 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:29 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:10 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:17 PM		Kairos Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/24/2024
8:00 PM		Bae Hyun W. (Reporting)
Kairos Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Kairos Pharma (Issuer)
Yu John S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Kairos Pharma (Issuer)
Keyoung Hansoo Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Kairos Pharma (Issuer)
MAZANET ROSEMARY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
8:00 PM		Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2024
3:22 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
3:15 PM		Kairos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:36 AM		Kairos Pharma (Filer)
Form 424B4
09/16/2024
11:15 PM		Kairos Pharma (Filer)
Form EFFECT
09/12/2024
12:57 PM		Kairos Pharma (Filer)
Form CERT
09/12/2024
11:44 AM		Kairos Pharma (Filer)
Form 8-A12B
08/16/2024
4:30 PM		Kairos Pharma (Filer)
Form S-1/A
06/03/2024
8:13 PM		Kairos Pharma (Filer)
Form S-1/A
05/20/2024
7:07 AM		Kairos Pharma (Filer)
Form S-1/A
05/10/2024
7:14 PM		Kairos Pharma (Filer)
Form S-1/A
04/30/2024
7:43 PM		Kairos Pharma (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSEAMERICAN:KAPA) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners
Feds Just Admitted It—They Can Take Your Cash
The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...
Priority Gold | Sponsored
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...
InvestorPlace | Sponsored
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...
Porter & Company | Sponsored
All Signs Point To Collapse - 401(k)s/IRAs /Are Doomed
Retiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road Ahead
American Hartford Gold | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Trump’s Secret Weapon
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored